The human immunodeficiency virus-1 nef gene product: a positive factor for viral infection and replication in primary lymphocytes and macrophages.
Open accessThe DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Abstract
Considerable controversy and uncertainty have surrounded the biological function of the Human Immunodeficiency Virus (HIV)-1 nef gene product. Initial studies suggested that this early, nonstructural viral protein functioned as a negative regulatory factor; thus, it was proposed to play a role in establishing or maintaining viral latency. In contrast, studies in Simian Immunodeficiency Virus (SIV)mac-infected rhesus monkeys have suggested that Nef is not a negative factor but rather plays a central role in promoting high-level viral replication and is required for viral pathogenesis in vivo. We sought to define a tissue culture system that would approximate the in vivo setting for virus infection in order to assess the role of HIV-1 Nef in viral replication. We show that infection of mitogen-activated peripheral blood mononuclear cells (PBMC) with Nef+ HIV results in enhanced replication as evidenced by earlier gag p24 expression when compared with infections performed with nef mutant viruses. Moreover, when unstimulated freshly isolated PBMC are infected with Nef+ and Nef- viruses and then subsequently activated with mitogen, the Nef-induced difference in viral replication kinetics is even more pronounced, with the Nef- viruses requiring much more time in culture for appreciable growth. A positive effect of Nef on viral replication was also observed in primary macrophages infected with a recombinant of YU-2, a patient-derived molecular clone with macrophage tropism. These positive effects of Nef on viral replication are dependent on the initial multiplicity of infection (MOI), in that infections of unstimulated PBMC at low MOI are most dependent upon intact nef for subsequent viral growth. We now provide evidence that the Nef+ HIV is more infectious than Nef- HIV from both a tissue culture infectious dose analysis, and a single-cell HIV infection assay. In the latter case, we demonstrate that infection with equivalent doses of HIV based on virion-associated gag p24 yields five- to sixfold more infected cells if Nef+ viral stocks were used. Furthermore, we find that the differential infectivity is not dependent on CD4 down-regulation as Nef+ virus produced from transfected COS cells lacking CD4 is also more infectious. However, normalization of PBMC infections to equivalent infectivity between that of the Nef+ and Nef- viruses continues to reveal delayed viral replication in the absence of Nef, suggesting that secondary viral spread in PBMC is also enhanced in Nef+ infections. We demonstrate this directly by showing a 13-15-fold increase in infectivity of PBMC-derived Nef+ HIC.(ABSTRACT TRUNCATED AT 400 WORDS)
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Current Protocols in Immunology
(2018) · Current Protocols in Immunology · doi:10.1002/(issn)1934-368x · Cited by 3,566
Importance of the nef gene for maintenance of high virus loads and for development of AIDS
Kestier, H. W., Ringler, D. J., Mori, K., Panicali, D. L., Sehgal, P. K., Daniel, M. D., & Desrosiers, R. C. (1991) · Cell · doi:10.1016/0092-8674(91)90097-i · Cited by 1,596
Zack, J. A., Arrigo, S. J., Weitsman, S. R., Go, A. S., Haislip, A., & Chen, I. S. Y. (1990) · Cell · doi:10.1016/0092-8674(90)90802-l · Cited by 1,517 · cited 1×
“Previous reports have defined the capacity of resting T cells to be infected based on DNA PCR for evidence of early products of reverse transcription (45-47).”
BackgroundNucleotide sequence of the AIDS virus, LAV
Wain-Hobson, S., Sonigo, P., Danos, O., Cole, S., & Alizon, M. (1985) · Cell · doi:10.1016/0092-8674(85)90303-4 · Cited by 1,202
Protective Effects of a Live Attenuated SIV Vaccine with a Deletion in the nef Gene
Daniel, M. D., Kirchhoff, F., Czajak, S. C., Sehgal, P. K., & Desrosiers, R. C. (1992) · Science · doi:10.1126/science.1470917 · Cited by 1,015
Kimpton, J., & Emerman, M. (1992) · Journal of Virology · doi:10.1128/jvi.66.4.2232-2239.1992 · Cited by 908
HIV-1 replication is controlled at the level of T cell activation and proviral integration.
Stevenson, M., Stanwick, T. L., Dempsey, M. P., & Lamonica, C. A. (1990) · The EMBO Journal · doi:10.1002/j.1460-2075.1990.tb08274.x · Cited by 800
Serine phosphorylation-independent downregulation of cell-surface CD4 by nef
Garcia, J. V., & Miller, A. D. (1991) · Nature · doi:10.1038/350508a0 · Cited by 760
Feinberg, M. B., Jarrett, R. F., Aldovini, A., Gallo, R. C., & Wong-Staal, F. (1986) · Cell · doi:10.1016/0092-8674(86)90062-0 · Cited by 669
Self-citationVeillette, A., Bookman, M. A., Horak, E. M., Samelson, L. E., & Bolen, J. B. (1989) · Nature · doi:10.1038/338257a0 · Cited by 659
Cited by
In Vivo Gene Delivery and Stable Transduction of Nondividing Cells by a Lentiviral Vector
Naldini, L., Blömer, U., Gallay, P., Ory, D., Mulligan, R., Gage, F. H., Verma, I. M., & Trono, D. (1996) · Science · doi:10.1126/science.272.5259.263 · Cited by 4,903
Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo
Zufferey, R., Nagy, D., Mandel, R. J., Naldini, L., & Trono, D. (1997) · Nature Biotechnology · doi:10.1038/nbt0997-871 · Cited by 1,977
Saksela, K., Cheng, G., & Baltimore, D. (1995) · The EMBO Journal · doi:10.1002/j.1460-2075.1995.tb07024.x · Cited by 552
Pathogenicity of Live, Attenuated SIV After Mucosal Infection of Neonatal Macaques
Baba, T. W., Jeong, Y. S., Pennick, D., Bronson, R., Greene, M. F., & Ruprecht, R. M. (1995) · Science · doi:10.1126/science.7892606 · Cited by 489
SERINC3 and SERINC5 restrict HIV-1 infectivity and are counteracted by Nef
Usami, Y., Wu, Y., & Göttlinger, H. G. (2015) · Nature · doi:10.1038/nature15400 · Cited by 467
Hanna, Z., Kay, D. G., Rebai, N., Guimond, A., Jothy, S., & Jolicoeur, P. (1998) · Cell · doi:10.1016/s0092-8674(00)81748-1 · Cited by 450
Stevenson, M. (2003) · Nature Medicine · doi:10.1038/nm0703-853 · Cited by 441
G-quadruplexes and G-quadruplex ligands: targets and tools in antiviral therapy
Ruggiero, E., & Richter, S. N. (2018) · Nucleic Acids Research · doi:10.1093/nar/gky187 · Cited by 440
Nef stimulates human immunodeficiency virus type 1 proviral DNA synthesis
Aiken, C., & Trono, D. (1995) · Journal of Virology · doi:10.1128/jvi.69.8.5048-5056.1995 · Cited by 385
Optimal infectivity in vitro of human immunodeficiency virus type 1 requires an intact nef gene
Chowers, M. Y., Spina, C. A., Kwoh, T. J., Fitch, N. J., Richman, D. D., & Guatelli, J. C. (1994) · Journal of Virology · doi:10.1128/jvi.68.5.2906-2914.1994 · Cited by 364
Baba, T. W., Liska, V., Khimani, A. H., Ray, N. B., Dailey, P. J., Penninck, D., Bronson, R., Greene, M. F., McClure, H. M., Martin, L. N., et al. (1999) · Nature Medicine · doi:10.1038/5557 · Cited by 356
Aiken, C. (1997) · Journal of Virology · doi:10.1128/jvi.71.8.5871-5877.1997 · Cited by 356
Grzesiek, S., Stahl, S. J., Wingfield, P. T., & Bax, A. (1996) · Biochemistry · doi:10.1021/bi9611164 · Cited by 349
Selective Transcription and Modulation of Resting T Cell Activity by Preintegrated HIV DNA
Wu, Y., & Marsh, J. W. (2001) · Science · doi:10.1126/science.1061548 · Cited by 343
Learmont, J. C., Geczy, A. F., Mills, J., Ashton, L. J., Raynes-Greenow, C. H., Garsia, R. J., Dyer, W. B., McIntyre, L., Oelrichs, R. B., Rhodes, D. I., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199906033402203 · Cited by 329
Lentiviruses as gene transfer agents for delivery to non-dividing cells
Naldini, L. (1998) · Current Opinion in Biotechnology · doi:10.1016/s0958-1669(98)80029-3 · Cited by 303
Greenberg, M. E. (1998) · The EMBO Journal · doi:10.1093/emboj/17.10.2777 · Cited by 300
The Restriction Factors of Human Immunodeficiency Virus
Harris, R. S., Hultquist, J. F., & Evans, D. T. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.r112.416925 · Cited by 287
HIV accessory proteins: Leading roles for the supporting cast
Trono, D. (1995) · Cell · doi:10.1016/0092-8674(95)90306-2 · Cited by 279
Wiskerchen, M., & Muesing, M. A. (1995) · Journal of Virology · doi:10.1128/jvi.69.1.376-386.1995 · Cited by 273
Schwartz, O., Maréchal, V, Danos, O., & Heard, J. M. (1995) · Journal of Virology · doi:10.1128/jvi.69.7.4053-4059.1995 · Cited by 270
Simmons, A., Aluvihare, V., & McMichael, A. (2001) · Immunity · doi:10.1016/s1074-7613(01)00158-3 · Cited by 270
Minimal Requirement for a Lentivirus Vector Based on Human Immunodeficiency Virus Type 1
Kim, V. N., Mitrophanous, K., Kingsman, S. M., & Kingsman, A. J. (1998) · Journal of Virology · doi:10.1128/jvi.72.1.811-816.1998 · Cited by 269
Craig, H. M., Pandori, M. W., & Guatelli, J. C. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.19.11229 · Cited by 268
Gorry, P. R., Bristol, G., Zack, J. A., Ritola, K., Swanstrom, R., Birch, C. J., Bell, J. E., Bannert, N., Crawford, K., Wang, H., et al. (2001) · Journal of Virology · doi:10.1128/jvi.75.21.10073-10089.2001 · Cited by 265
Ross, T. M., Oran, A. E., & Cullen, B. R. (1999) · Current Biology · doi:10.1016/s0960-9822(99)80283-8 · Cited by 253
Human Immunodeficiency Virus Type 1 Nef: Adapting to Intracellular Trafficking Pathways
Roeth, J. F., & Collins, K. L. (2006) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00042-05 · Cited by 193
“The accessory protein Nef was originally named because it was thought to be a negative factor that inhibited viral replication (29); however, it has become clear that Nef positively affects viral replication and infectivity (109, 110).”
BackgroundCampbell, E. M., Nunez, R., & Hope, T. J. (2004) · Journal of Virology · doi:10.1128/jvi.78.11.5745-5755.2004 · Cited by 177
“One of the known aspects of the ability of HIV Nef to enhance HIV infectivity is that the stimulatory effect is variable, depending on virus preparation and target cells (4, 31).”
BackgroundResultRhee, S. S., & Marsh, J. W. (1994) · Journal of Virology · doi:10.1128/jvi.68.8.5156-5163.1994 · Cited by 174
“The relevance of this positive effect of Nef is supported by ex vivo studies of HIV-1 in which Nef protein has enhanced the ability of primary, quiescent human lymphocytes to replicate HIV-1 (15, 41, 59).”
BackgroundRücker, E., Grivel, J.-C., Münch, J., Kirchhoff, F., & Margolis, L. (2004) · Journal of Virology · doi:10.1128/jvi.78.22.12689-12693.2004 · Cited by 48
Malbec, M., Roesch, F., & Schwartz, O. (2011) · Viruses · doi:10.3390/v3030254 · Cited by 21
“Functions Nef p8/p12 Increase of infectivity in vitro + [7] + [8] Required for infection in vivo + [9] + [10] TCR down-regulation + [11] + [12] MHC-I down-regulation + [13] + [14] Increase of IL-2 production + [15] + [16] Immune synapse modulation + [11] + [4] Increase of viral cell-to-cell transmission +/− [17] + [1]…”
Metadata
- Authors
- Miller, M. D., Warmerdam, M. T., Gaston, I., Greene, W. C., & Feinberg, M. B.
- Venue
- The Journal of experimental medicine
- Publisher
- Rockefeller University Press
- Published
- 1994-01-01
- Volume
- 179
- Issue
- 1
- Pages
- 101-113
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- OpenAlex
- W2163644060
- Cited by
- 527
- References
- 43
- FWCI
- 15.65
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.